Highridge Medical licensed the U.S. rights for the activL lumbar artificial disc implant, according to a July 8 news release.
The company is “imminently” beginning production for the launch of its activL disc for later in 2025. Highridge’s disc replacement portfolio also includes the Mobi-C disc for 1- and 2-level cervical disc replacements.
“True to our continued commitment to bringing unique motion preservation solutions to market, the activL lumbar disc is a great strategic fit for our business,” Rebecca Whitney, CEO of Highridge, said in the release. “This addition expands our leadership position in spinal motion preservation solutions to now include lumbar disc arthroplasty with a solution already trusted and preferred by many spine surgeons.”
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
